Biosimilar Epoetin Zeta in Oncology and Haematology: Development and Experience following 6 Years of Use

Publisher： Karger

E-ISSN： 1421-9662|135|1|44-52

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.1, 2015-0, pp. : 44-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the therapeutic effects of epoetin zeta and epoetin alfa in the correction of renal anaemia

By Krivoshiev Stefan   Todorov Vasil V.   Manitius Jacek   Czekalski Stanislaw   Scigalla Paul   Koytchev Rossen    

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1407-1415

Informa Healthcare

Access to resources Recommend Favorite

A development framework for the consultant radiographer in oncology: the Leeds experience

By  

Journal of Radiotherapy in Practice, Vol. 15, Iss. 2, 2016-03 ,pp. : 210-214

Cambridge University Press

Access to resources Recommend Favorite

Clinical experience with infliximab biosimilar in psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : e347-e348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia

By Tzekova Valentina   Mihaylov Georgi   Elezovic Ivo   Koytchev Rossen  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1689-1697

Informa Healthcare

Access to resources Recommend Favorite

Bilateral diaphragm paralysis following cardiac surgery in children: 10-years' experience

By Dagan Ovadia   Nimri Revital   Katz Yakov   Birk Einat   Vidne Bernardo  

Intensive Care Medicine, Vol. 32, Iss. 8, 2006-08 ,pp. : 1222-1226

Springer Publishing Company

Access to resources Recommend Favorite